Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-4 of  4 results for ""Porphyria, Acute Intermittent""

Your Filters

Content Provider : Gale in Context
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
News

Global Porphyria Pipeline Market Research Report 2021 Featuring Agios Pharma, Alnylam Pharma, Clinuvel Pharma, Mitsubishi Tanabe, Moderna, Palatin Technologies, & Recordati Rare Diseases.

  • Source: PR Newswire. November 15, 2021

Record details

Read Online Read More Add to Saved list
×
News

uniQure Initiates Phase I in Acute Intermittent Porphyria.

  • Source: PR Newswire. Dec 11, 2012

Record details

Read Online Read More Add to Saved list
×
News

AMT Receives EUR 1.1 Million Funding for Acute Intermittent Porphyria Gene Therapy as part of EU Consortium Grant.

  • Source: PR Newswire. Jan 31, 2011

Record details

Read Online Read More Add to Saved list
×
News

AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria.

  • Source: PR Newswire. May 28, 2009

Record details

Read Online Read More Add to Saved list
×
  • 1-4 of  4 results for ""Porphyria, Acute Intermittent""